DK1461049T3 - Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder - Google Patents

Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder

Info

Publication number
DK1461049T3
DK1461049T3 DK03700633T DK03700633T DK1461049T3 DK 1461049 T3 DK1461049 T3 DK 1461049T3 DK 03700633 T DK03700633 T DK 03700633T DK 03700633 T DK03700633 T DK 03700633T DK 1461049 T3 DK1461049 T3 DK 1461049T3
Authority
DK
Denmark
Prior art keywords
pregnant woman
labor
myometrium
cervix
molecular weight
Prior art date
Application number
DK03700633T
Other languages
English (en)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmstroem
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Application granted granted Critical
Publication of DK1461049T3 publication Critical patent/DK1461049T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03700633T 2002-01-02 2003-01-02 Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder DK1461049T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0200005A SE521676C2 (sv) 2002-01-02 2002-01-02 Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
PCT/SE2003/000004 WO2003055499A1 (en) 2002-01-02 2003-01-02 Use of sulfated glycosaminoglycans for establishing effective labor in women

Publications (1)

Publication Number Publication Date
DK1461049T3 true DK1461049T3 (da) 2008-09-15

Family

ID=20286575

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03700633T DK1461049T3 (da) 2002-01-02 2003-01-02 Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder

Country Status (22)

Country Link
US (3) US7407945B2 (da)
EP (1) EP1461049B1 (da)
JP (1) JP4434741B2 (da)
KR (1) KR100958691B1 (da)
CN (1) CN100341518C (da)
AT (1) ATE395067T1 (da)
AU (1) AU2003201787B2 (da)
CA (1) CA2472093C (da)
CY (1) CY1108260T1 (da)
DE (1) DE60320931D1 (da)
DK (1) DK1461049T3 (da)
ES (1) ES2306852T3 (da)
HK (1) HK1076389A1 (da)
IL (2) IL162664A0 (da)
NO (1) NO332702B1 (da)
NZ (1) NZ533856A (da)
PL (1) PL206458B1 (da)
PT (1) PT1461049E (da)
SE (1) SE521676C2 (da)
SI (1) SI1461049T1 (da)
WO (1) WO2003055499A1 (da)
ZA (1) ZA200405015B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
RS56874B1 (sr) * 2011-12-19 2018-04-30 Dilafor Ab Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2014143017A (ru) * 2012-03-26 2016-05-20 Дилафор Аб Препараты для индукции родов
RU2014143008A (ru) * 2012-03-26 2016-05-20 Дилафор Аб Способ лечения остановки родов
UA117912C2 (uk) * 2012-05-08 2018-10-25 Ділафор Аб Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк)
AU2013296240B2 (en) 2012-08-03 2018-05-17 Lfb Usa, Inc. The use of antithrombin in extracorporeal membrane oxygenation
IL295184A (en) 2020-02-17 2022-09-01 Dilafor Ab Tapoxiferine for the treatment of preeclampsia
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AR129190A1 (es) 2022-05-03 2024-07-31 Dilafor Ab Nuevo uso médico de la tafoxiparina

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US5190926A (en) * 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
SE8702254D0 (sv) 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US6020322A (en) * 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5411947A (en) * 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
US5543389A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
AU722214B2 (en) * 1995-06-07 2000-07-27 Centre National De La Recherche Scientifique (Cnrs) Nucleosides with anti-hepatitis B virus activity
US6025335A (en) * 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
CA2240328A1 (en) * 1996-10-15 1998-04-23 Toray Industries, Inc. Cervical canal maturing agent
JP4412756B2 (ja) 1998-02-26 2010-02-10 生化学工業株式会社 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet

Also Published As

Publication number Publication date
JP4434741B2 (ja) 2010-03-17
ZA200405015B (en) 2005-08-31
US8524688B2 (en) 2013-09-03
CY1108260T1 (el) 2014-02-12
SE0200005L (sv) 2003-07-03
IL162664A (en) 2009-06-15
US8207145B2 (en) 2012-06-26
KR20040075917A (ko) 2004-08-30
NZ533856A (en) 2004-12-24
DE60320931D1 (de) 2008-06-26
IL162664A0 (en) 2005-11-20
CA2472093C (en) 2011-02-22
CN100341518C (zh) 2007-10-10
SE521676C2 (sv) 2003-11-25
ATE395067T1 (de) 2008-05-15
CN1612741A (zh) 2005-05-04
AU2003201787A1 (en) 2003-07-15
SE0200005D0 (sv) 2002-01-02
SI1461049T1 (sl) 2008-12-31
US20120225843A1 (en) 2012-09-06
AU2003201787B2 (en) 2008-02-28
EP1461049B1 (en) 2008-05-14
NO332702B1 (no) 2012-12-10
KR100958691B1 (ko) 2010-05-18
PL370428A1 (en) 2005-05-30
CA2472093A1 (en) 2003-07-10
US7407945B2 (en) 2008-08-05
EP1461049A1 (en) 2004-09-29
US20080269165A1 (en) 2008-10-30
US20050075314A1 (en) 2005-04-07
PT1461049E (pt) 2008-08-22
NO20043190L (no) 2004-07-26
WO2003055499A1 (en) 2003-07-10
PL206458B1 (pl) 2010-08-31
ES2306852T3 (es) 2008-11-16
JP2005513148A (ja) 2005-05-12
HK1076389A1 (en) 2006-01-20

Similar Documents

Publication Publication Date Title
HK1076389A1 (en) Use of sulfated glycosaminoglycans for the manufacture of a pharmaceutical preparation for the prevention and treatment of slow progress of term labor
BRPI0511603A (pt) método para o tratamento de distúrbios do sangramento com a utilização de polissacarìdeos sulfatados
Shaughnessy et al. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
Kuderer et al. Guidelines for treatment and prevention of venous thromboembolism among patients with cancer
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
KR20160088914A (ko) 새로운 만성 궤양 치료제
Yüksel et al. Management of lymphoedema
MX2007011002A (es) Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica.
DE602004018944D1 (de) Verwendung von abführmittel zur behandlung des reizdarmsyndroms
ES2141922T3 (es) Tiazepinonas de benzotiofeno, benzofurano e indol, oxazepinonas y diazepinonas usadas como inhibidores de la adherencia celular y del vih.
Thodiyil et al. Thromboprophylaxis in the cancer patient
DE60143078D1 (de) Pax2 zur behandlung von nierenkrankheiten
DE60025698D1 (de) Neue dialysemethode
BRPI0414887A (pt) métodos de tratamento, prevenção, retardo do inìcio ou redução dos efeitos de citocinas pró-inflamatórias em um mamìfero e de tratamento, prevenção, retardo do inìcio de uma condição associada com um efeito de citocinas pró-inflamatórias em um mamìfero, e, composição farmacêutica
WO2005060960A3 (en) Use of histamine to treat bone disease
WO2005044189A3 (en) Dialysates and methods and systems related thereto
RS51420B (en) HYPERSTRUCTURE AMYLOPECTIN FOR USE IN THE PROCEDURES OF SURGICAL OR THERAPEUTIC TREATMENT OF mammals OR IN THE PROCEDURES OF DIAGNOSIS, AND PARTICULARLY FOR USE AS A PLASMA VOLUME EXPANDER
DE60112768D1 (de) Behandlung von entzündlichen erkrankungen
RU2014149230A (ru) Лечение послеродового кровотечения (прк)
ATE324905T1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
Rockson Lymphedema
Poseryaev et al. METHODS OF CONSERVATIVE TREATMENT OF VENOUS TROPHIC ULCERS ON THE OUTPATIENT STAGE
US10869949B2 (en) Method for treating subjects suffering from chronic ulcers
FR2811572B1 (fr) Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose